Date published: 2026-4-1

1-800-457-3801

SCBT Portrait Logo
Seach Input

MUP9 Activators

MUP9 is a member of the Major Urinary Protein (MUP) family, proteins primarily known for their role in the transport and release of pheromones in mammals. These small, lipocalin proteins bind small volatile chemicals and facilitate their slow release, influencing social and reproductive behaviors in animals. MUPs are structurally characterized by a beta-barrel fold that encapsulates the ligand-binding site, which is key to their function in binding and releasing pheromones and other small volatile molecules. The activation of MUP9, as with other MUPs, is intricately linked to its structure and the biochemical environment. Activation, in this context, refers to the protein's ability to bind and release ligands effectively, a process influenced by various biochemical modifications and interactions. Phosphorylation, one of the most common post-translational modifications, plays a significant role in this regard. Kinases like PKC, PKA, and SAPKs, upon activation by specific activators like PMA, forskolin, or anisomycin, can phosphorylate MUP9. This phosphorylation alters the conformation of MUP9, which may influence its ligand-binding affinity and release kinetics, effectively modulating its functional activity. In addition to phosphorylation, the intracellular calcium level is another critical factor in MUP9's activation. Calcium-binding proteins, such as calmodulin, can be activated in the presence of increased intracellular calcium levels, triggered by compounds like ionomycin or thapsigargin. These proteins, once activated, can interact with and potentially modulate the activity of MUP9. The precise mechanism of how calcium signaling influences MUP9 remains an area of exploration, but it is hypothesized that it could impact the protein's structure or interact with other modulatory proteins. In summary, the activation of MUP9 is a multifaceted process influenced by various biochemical pathways and modifications. Understanding these mechanisms is crucial for comprehending how MUPs function in biological systems, particularly in the context of pheromone transport and release. The role of phosphorylation and calcium signaling in modulating MUP9's activity highlights the complex interplay of cellular processes in regulating protein function. As research advances, further insights into the specific activation mechanisms of MUP9 will enhance our understanding of the functional dynamics of the MUP family and their role in mammalian biology.

SEE ALSO...

Items 1 to 10 of 11 total

Display:

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

PMA

16561-29-8sc-3576
sc-3576A
sc-3576B
sc-3576C
sc-3576D
1 mg
5 mg
10 mg
25 mg
100 mg
$41.00
$132.00
$214.00
$500.00
$948.00
119
(6)

Phorbol 12-myristate 13-acetate (PMA) activates protein kinase C (PKC), which in turn can activate MUP9. PKC phosphorylates specific serine/threonine residues on target proteins, leading to the activation of MUP9 by modifying its conformation and functional state.

Bryostatin 1

83314-01-6sc-201407
10 µg
$245.00
9
(1)

Bryostatin 1, a potent modulator of PKC, indirectly activates MUP9 by binding to the regulatory domain of PKC. This binding enhances PKC's catalytic activity, resulting in the phosphorylation and consequent activation of MUP9.

Ionomycin

56092-82-1sc-3592
sc-3592A
1 mg
5 mg
$78.00
$270.00
80
(4)

Ionomycin is a calcium ionophore that increases intracellular calcium levels. Elevated calcium activates calmodulin, which in turn can activate various kinases such as CaMKII that phosphorylate and activate MUP9.

Okadaic Acid

78111-17-8sc-3513
sc-3513A
sc-3513B
25 µg
100 µg
1 mg
$291.00
$530.00
$1800.00
78
(4)

Okadaic Acid is a potent inhibitor of protein phosphatases 1 and 2A. Inhibition of these phosphatases leads to increased phosphorylation levels of several proteins, potentially including MUP9, thereby promoting its activation.

Thapsigargin

67526-95-8sc-24017
sc-24017A
1 mg
5 mg
$136.00
$446.00
114
(2)

Thapsigargin inhibits the sarcoplasmic/endoplasmic reticulum Ca2+ ATPase (SERCA), leading to an increase in cytosolic calcium levels. This can activate calcium-dependent kinases, which may phosphorylate and activate MUP9.

Dibutyryl-cAMP

16980-89-5sc-201567
sc-201567A
sc-201567B
sc-201567C
20 mg
100 mg
500 mg
10 g
$47.00
$136.00
$492.00
$4552.00
74
(7)

Dibutyryl-cAMP, a cAMP analog, activates PKA. PKA then phosphorylates various substrates, potentially including MUP9, resulting in its activation. This compound serves as a stable mimic of cAMP, enhancing PKA's activity.

Staurosporine

62996-74-1sc-3510
sc-3510A
sc-3510B
100 µg
1 mg
5 mg
$82.00
$153.00
$396.00
113
(4)

Staurosporine, a potent PKC inhibitor, can paradoxically activate PKC at low concentrations. This activation may lead to the phosphorylation and subsequent activation of MUP9 through PKC's kinase activity.

Phorbol-12,13-dibutyrate

37558-16-0sc-202285
1 mg
$124.00
3
(1)

Phorbol 12,13-dibutyrate (PDBu) is a PKC activator. It binds to the regulatory domain of PKC, promoting its activation. Activated PKC may then phosphorylate and activate MUP9.

Calphostin C

121263-19-2sc-3545
sc-3545A
100 µg
1 mg
$343.00
$1642.00
20
(1)

Calphostin C, a PKC inhibitor, can activate PKC at specific concentrations. This activation leads to phosphorylation of target proteins, potentially including MUP9, thus promoting its functional activation.

Gö 6983

133053-19-7sc-203432
sc-203432A
sc-203432B
1 mg
5 mg
10 mg
$105.00
$299.00
$474.00
15
(1)

Go 6983 is a pan-PKC inhibitor that, under certain conditions, can activate PKC. This activation can lead to the phosphorylation of several proteins, including MUP9, enhancing its activation.